<DOC>
	<DOCNO>NCT02703558</DOCNO>
	<brief_summary>This study prospective randomize control study . Female patient 18 year age , present treatment pelvic organ prolapse and/or stress urinary incontinence Pelvic Floor Center Johns Hopkins Bayview Medical Center , consent undergo urogynecologic surgical procedure , consider inclusion study . Their history review attend surgeon meet inclusion exclusion criterion , recruit participation . The primary investigator co-investigators ( attend physician , fellow ) determine patient eligibility . Regarding privacy issue , patient consent procedure study careful attention make emphasize patient confidentiality . When patient present surgery , randomize receive either preoperative pyridium intraoperative fluorescein dye . Given color difference dye , blind occur . The process recruitment consistent deviation protocol report Johns Hopkins Internal Review Board .</brief_summary>
	<brief_title>Evaluation Fluorescein Use During Cystoscopy</brief_title>
	<detailed_description />
	<criteria>â€¢ English speaking , female patient , age 18 older , undergo urogynecologic surgery pelvic organ prolapse urinary incontinence plan concomitant cystoscopy Johns Hopkins Bayview NonEnglish speaking , Known allergic reaction sensitivity sodium fluorescein phenazopyridine Known glucose6phosphate dehydrogenase nicotinamide adenine dinucleotide methemoglobin reductase deficiency Pregnant breastfeed Known renal disease renal failure Undergoing concomitant nonurogynecologic procedure Dementia cognitive impairment</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>